Skip to main content Scroll Top

Actualités

  • Accueil
  • Alzheimer
  • Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Posts les plus vus
Clear Filters
MedInTechs 2026 – Parc Floral de Paris | 9 & 10 MARS
‘Beyond-the-brain’ strategy: a new photobiomodulation technique produces a neuroprotective effect in a mouse model of Alzheimer’s disease by synergistic mechanisms when targeting brain and guts
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis

Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation

15th Clinical Trials on Alzheimer’s Disease (CTAD) 2022, San Francisco
CTAD 2023

Julien Delrieu, Aroa Relano-Gines, Patrice Cristofini, Julie Bisiaux, Sara Guillemin, Guillaume Blivet, Jacques Touchon

Partagez cet article